Not Your Father s Farmland Market (even if he still owns the farm.)

Size: px
Start display at page:

Download "Not Your Father s Farmland Market (even if he still owns the farm.)"

Transcription

1 Not Your Father s Farmland Market (even if he still owns the farm.) DTN Conference December 2016 Chicago, Illinois Bruce J. Sherrick, Ph.D. TIAA Center for Farmland Research, University of Illinois Advancing Farmland Markets through Research and Information

2 TIAA Center for Farmland Research Advancing Farmland Markets through Research and Information C o n t e x t Goals: improve accuracy and understanding of asset class, and to provide unbiased research and useful tools for those involved with farmland investments. Tools and articles at:

3 Balance Sheet of Ag Sector -- US ($ millions, except ratios - source ERS-USDA) Farm Assets 278,823 1,000, ,609 1,203,215 2,161,362 2,310,640 2,777,810 2,861,816 Real Estate 202, , , ,428 1,651,379 1,795,126 2,252,907 2,342,314 Non Real Estate 76, , , , , , , ,503 Farm Debt 48, , , , , , , ,261 Real Estate 27,238 85,272 67,633 84, , , , ,091 Non Real Estate 21,263 77,160 63,483 79, , , , ,170 Equity 230, , ,493 1,039,285 1,882,431 2,016,168 2,462,835 2,497,555 Selected Indicators Debt/Equity 21.1% 19.4% 18.5% 15.8% 14.8% 14.6% 12.8% 14.6% Debt/Assets 17.4% 16.2% 15.6% 13.6% 12.9% 12.7% 11.3% 12.7% Real Estate/Equity 87.9% 93.4% 87.3% 91.1% 87.7% 89.0% 91.5% 93.8% Real Estate/Assets 72.6% 78.2% 73.7% 78.7% 76.4% 77.7% 81.1% 81.8% Real Estate D/Total D 56.2% 52.5% 51.6% 51.7% 55.2% 56.8% 58.7% 56.3%

4 Ag Sector Balance Sheet -- US C o n t e x t Farmland represents 80+% of farm assets Farm real estate debt only 57% of total farm debt Low aggregate leverage (approx. 13% D/A) Growth rates , continuous compounding: Assets --5.3% Real Estate % Debt 4.2% Equity 5.6% Absence of active equity market. Some key efforts underway. Ag Balance sheet compared to corporate sector vastly different, especially in financial structure. Early stage financialization.

5 Yield Curve August 2001-October 21, 2016 (weekly) Sept. 19, 2008 Liquidity puddle Rate hike 12/15

6 Does the farmland market make sense? Historic comparison of implied cap rate and CMT-10 One period in 1980 s where conditions that might be considered bubble formation existed. Implied asset value from capitalization of income to q2:16. Recent asset values show that the market did not consider income levels in recent years to be permanent

7 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 10.54% 6.41% S&P % 16.74% NASDAQ 9.71% 25.53% TCM10Y 6.67% 2.88% AAA 7.79% 2.50% Mort30F 8.35% 3.06% Gold 7.40% 23.04% All REITS 9.09% 20.34% CPI 4.00% 2.86%

8 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 8.53% 5.27% S&P % 16.09% NASDAQ 9.71% 25.53% TCM10Y 6.44% 3.18% AAA 7.67% 2.79% Mort30F 8.22% 3.36% Gold 2.02% 16.29% All REITS 10.33% 17.31% CPI 3.14% 2.11%

9 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 9.27% 3.70% S&P % 17.55% NASDAQ 9.23% 27.44% TCM10Y 4.85% 1.80% AAA 6.25% 1.51% Mort30F 6.50% 1.70% Gold 3.76% 14.54% All REITS 9.77% 19.04% CPI 2.44% 1.13%

10 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 9.27% 4.54% S&P % 18.80% NASDAQ 1.30% 27.47% TCM10Y 3.71% 1.15% AAA 5.33% 1.06% Mort30F 5.48% 1.23% Gold 8.10% 15.45% All REITS 11.01% 19.77% CPI 2.15% 1.03%

11 Annualized Return Buy (beginning of year) Farmland: time and holding periods Iowa Sell (end of year) % 16.3% 21.6% 23.0% 24.8% 26.8% 24.6% 24.1% 23.9% 22.8% 20.6% 18.2% 16.3% 12.8% 10.8% 10.0% 10.9% 11.5% 11.3% 11.3% 11.2% 11.3% 11.3% 11.3% 11.4% 11.5% 11.5% 11.4% 11.3% 11.2% 11.1% 11.0% 11.1% 11.4% 11.5% 11.7% 11.9% 11.5% 11.7% 12.0% 12.2% 12.4% 12.4% 12.0% % 26.0% 26.4% 27.8% 29.8% 26.6% 25.7% 25.3% 23.9% 21.3% 18.6% 16.6% 12.8% 10.6% 9.8% 10.8% 11.4% 11.2% 11.2% 11.1% 11.2% 11.2% 11.2% 11.3% 11.5% 11.5% 11.4% 11.2% 11.1% 11.0% 11.0% 11.1% 11.4% 11.4% 11.6% 11.8% 11.5% 11.6% 12.0% 12.2% 12.4% 12.4% 12.0% % 30.0% 30.7% 32.5% 28.0% 26.8% 26.2% 24.5% 21.5% 18.5% 16.3% 12.2% 10.0% 9.1% 10.2% 10.9% 10.7% 10.8% 10.7% 10.8% 10.9% 10.9% 11.0% 11.2% 11.2% 11.1% 10.9% 10.8% 10.7% 10.7% 10.8% 11.1% 11.2% 11.4% 11.6% 11.3% 11.4% 11.8% 12.0% 12.2% 12.2% 11.8% % 29.7% 32.3% 26.9% 25.7% 25.1% 23.4% 20.2% 17.0% 14.8% 10.5% 8.3% 7.5% 8.7% 9.6% 9.5% 9.6% 9.6% 9.7% 9.9% 9.9% 10.1% 10.3% 10.3% 10.3% 10.2% 10.1% 10.0% 10.0% 10.1% 10.5% 10.6% 10.8% 11.1% 10.7% 10.9% 11.2% 11.5% 11.7% 11.7% 11.3% % 34.9% 26.7% 25.3% 24.7% 22.7% 19.2% 15.8% 13.5% 8.9% 6.7% 6.0% 7.4% 8.4% 8.4% 8.6% 8.6% 8.8% 9.0% 9.1% 9.3% 9.6% 9.7% 9.6% 9.5% 9.5% 9.4% 9.4% 9.6% 10.0% 10.1% 10.3% 10.6% 10.2% 10.4% 10.8% 11.1% 11.3% 11.4% 11.0% % 24.1% 23.0% 22.9% 20.9% 17.2% 13.7% 11.4% 6.6% 4.4% 3.9% 5.6% 6.8% 6.8% 7.2% 7.3% 7.6% 7.8% 8.0% 8.3% 8.6% 8.7% 8.7% 8.7% 8.6% 8.6% 8.7% 8.8% 9.3% 9.4% 9.7% 10.0% 9.6% 9.9% 10.3% 10.6% 10.8% 10.9% 10.5% % 16.3% 18.3% 17.0% 13.4% 10.1% 8.0% 3.3% 1.3% 1.0% 3.1% 4.5% 4.8% 5.3% 5.5% 5.9% 6.3% 6.6% 6.9% 7.3% 7.5% 7.6% 7.5% 7.6% 7.6% 7.7% 7.9% 8.4% 8.6% 8.9% 9.2% 8.9% 9.1% 9.5% 9.9% 10.1% 10.2% 9.8% % 21.7% 18.8% 13.8% 9.7% 7.4% 2.1% 0.0% -0.2% 2.2% 3.9% 4.2% 4.8% 5.1% 5.6% 6.0% 6.3% 6.6% 7.1% 7.3% 7.4% 7.4% 7.4% 7.4% 7.5% 7.8% 8.3% 8.4% 8.8% 9.1% 8.8% 9.0% 9.5% 9.8% 10.1% 10.2% 9.8% % 17.8% 11.6% 7.1% 4.9% -0.7% -2.7% -2.5% 0.3% 2.3% 2.8% 3.5% 4.0% 4.5% 5.0% 5.4% 5.9% 6.4% 6.6% 6.7% 6.8% 6.8% 6.9% 7.0% 7.3% 7.8% 8.0% 8.3% 8.7% 8.4% 8.7% 9.1% 9.5% 9.8% 9.9% 9.5% % 6.5% 2.4% 0.9% -4.8% -6.3% -5.6% -2.1% 0.3% 1.0% 2.0% 2.6% 3.3% 3.9% 4.4% 4.9% 5.5% 5.8% 6.0% 6.0% 6.1% 6.2% 6.4% 6.7% 7.3% 7.5% 7.9% 8.3% 7.9% 8.2% 8.7% 9.1% 9.4% 9.5% 9.1% % -2.6% -2.9% -8.9% -9.8% -8.5% -4.1% -1.2% -0.3% 0.9% 1.6% 2.5% 3.2% 3.8% 4.4% 5.0% 5.4% 5.6% 5.7% 5.8% 5.9% 6.1% 6.4% 7.0% 7.3% 7.7% 8.1% 7.7% 8.1% 8.6% 9.0% 9.3% 9.4% 9.0% % -4.3% -11.6% -12.1% -10.1% -4.8% -1.4% -0.3% 1.0% 1.8% 2.7% 3.5% 4.1% 4.7% 5.4% 5.7% 5.9% 6.0% 6.1% 6.2% 6.4% 6.7% 7.3% 7.6% 8.0% 8.4% 8.0% 8.4% 8.9% 9.3% 9.6% 9.7% 9.3% % -14.7% -14.3% -11.3% -4.7% -0.7% 0.4% 1.8% 2.6% 3.5% 4.3% 4.9% 5.5% 6.2% 6.5% 6.6% 6.7% 6.7% 6.8% 7.0% 7.3% 7.9% 8.2% 8.6% 9.0% 8.6% 8.9% 9.4% 9.8% 10.2% 10.2% 9.8% % -19.3% -13.8% -5.1% -0.2% 1.1% 2.6% 3.4% 4.3% 5.1% 5.7% 6.3% 6.9% 7.2% 7.3% 7.3% 7.4% 7.4% 7.6% 7.9% 8.5% 8.7% 9.1% 9.5% 9.1% 9.4% 9.9% 10.4% 10.7% 10.7% 10.2% % -7.7% 2.5% 7.1% 7.2% 8.0% 8.2% 8.7% 9.1% 9.3% 9.6% 10.1% 10.2% 10.1% 9.9% 9.8% 9.7% 9.7% 9.9% 10.5% 10.6% 11.0% 11.3% 10.8% 11.1% 11.6% 11.9% 12.2% 12.2% 11.6% % 11.6% 15.0% 13.1% 12.9% 12.3% 12.3% 12.3% 12.2% 12.3% 12.5% 12.4% 12.1% 11.8% 11.5% 11.3% 11.2% 11.4% 11.9% 12.0% 12.3% 12.6% 12.0% 12.2% 12.7% 13.0% 13.3% 13.2% 12.6% % 24.4% 18.5% 16.9% 15.3% 14.8% 14.4% 14.0% 13.9% 14.1% 13.8% 13.4% 12.9% 12.5% 12.3% 12.1% 12.2% 12.7% 12.8% 13.0% 13.3% 12.7% 12.9% 13.3% 13.7% 13.9% 13.8% 13.2% % 14.6% 13.8% 12.6% 12.6% 12.5% 12.3% 12.4% 12.8% 12.6% 12.2% 11.8% 11.5% 11.3% 11.2% 11.4% 12.0% 12.0% 12.4% 12.7% 12.0% 12.3% 12.8% 13.2% 13.4% 13.4% 12.7% % 9.8% 9.6% 10.3% 10.7% 10.8% 11.1% 11.6% 11.6% 11.3% 10.9% 10.7% 10.5% 10.5% 10.7% 11.4% 11.5% 11.8% 12.2% 11.5% 11.8% 12.4% 12.8% 13.0% 13.0% 12.4% % 10.7% 11.2% 11.5% 11.4% 11.7% 12.2% 12.1% 11.7% 11.3% 11.0% 10.8% 10.7% 10.9% 11.6% 11.7% 12.1% 12.5% 11.8% 12.0% 12.6% 13.0% 13.3% 13.3% 12.5% % 10.7% 11.2% 11.2% 11.6% 12.2% 12.1% 11.7% 11.2% 10.8% 10.6% 10.6% 10.8% 11.6% 11.7% 12.1% 12.5% 11.7% 12.0% 12.6% 13.1% 13.3% 13.3% 12.6% % 12.3% 11.9% 12.2% 12.9% 12.6% 12.0% 11.4% 11.0% 10.8% 10.7% 10.9% 11.8% 11.9% 12.3% 12.7% 11.9% 12.2% 12.8% 13.3% 13.5% 13.5% 12.7% % 11.8% 12.2% 13.0% 12.7% 12.0% 11.3% 10.9% 10.6% 10.5% 10.8% 11.7% 11.9% 12.3% 12.7% 11.9% 12.2% 12.9% 13.3% 13.6% 13.6% 12.7% % 12.2% 13.3% 12.8% 11.9% 11.1% 10.7% 10.4% 10.3% 10.7% 11.7% 11.8% 12.3% 12.8% 11.8% 12.2% 12.9% 13.4% 13.7% 13.6% 12.8% % 13.1% 14.3% 13.3% 12.1% 11.1% 10.6% 10.3% 10.2% 10.6% 11.7% 11.9% 12.4% 12.9% 11.9% 12.2% 13.0% 13.5% 13.8% 13.8% 12.8% % 13.4% 11.8% 10.6% 10.1% 9.9% 9.8% 10.3% 11.6% 11.8% 12.3% 12.9% 11.8% 12.2% 13.0% 13.5% 13.9% 13.8% 12.8% % 11.3% 9.9% 9.1% 8.8% 8.8% 8.9% 9.6% 11.1% 11.3% 12.0% 12.7% 11.5% 11.9% 12.8% 13.4% 13.8% 13.7% 12.7% % 7.9% 7.9% 8.1% 8.4% 9.3% 11.1% 11.3% 12.1% 12.8% 11.5% 12.0% 12.9% 13.5% 13.9% 13.8% 12.8% % 7.3% 7.6% 8.0% 8.4% 9.4% 11.5% 11.7% 12.5% 13.3% 11.8% 12.3% 13.3% 13.9% 14.3% 14.2% 13.0% % 8.3% 8.7% 10.0% 12.3% 12.5% 13.3% 14.0% 12.3% 12.8% 13.9% 14.5% 14.9% 14.7% 13.4% % 8.8% 9.2% 10.7% 13.5% 13.5% 14.2% 14.9% 12.9% 13.4% 14.5% 15.1% 15.5% 15.3% 13.8% % 11.7% 15.1% 14.7% 15.4% 16.0% 13.5% 14.0% 15.1% 15.8% 16.1% 15.8% 14.2% % 13.7% 17.9% 16.4% 16.8% 17.3% 14.1% 14.6% 15.8% 16.5% 16.8% 16.4% 14.6% % 17.7% 17.9% 18.2% 14.2% 14.8% 16.1% 16.9% 17.1% 16.7% 14.7% % Sold 13.4% 15.7% 16.9% 12.3% 13.3% 15.2% 16.1% 16.5% 16.0% 14.0% 2007 Bought 18.2% 18.7% 11.9% 13.3% 15.5% 16.6% 17.0% 16.4% 14.0% -30% % 8.9% 11.7% 14.9% 16.2% 16.8% 16.1% 13.5% % 8.1% 13.4% 15.5% 16.2% 15.6% 12.7% % 21.1% 21.4% 20.9% 19.2% 15.1% % 23.4% 22.0% 19.6% 14.6% (Illinois ) % 20.6% 17.9% 12.2% %--20% -20%--10% -10%-0% 0%-10% 10%-20% 20%-30% 30%-30% 19.4% 15.9% 9.1% % 4.3% %

12 Ave. Annual Return Average Annual return Farmland risk stability measures Holding period length: % 10% 8% 25 yr 20 yr 15 yr 10 yr 5 yr 3 yr 2 yr 1 yr 6% 4% 2% 0% 0% 2% 4% 6% 8% 10% 12% St.Dev. of Returns

13 Annualized Return Buy (beginning of year) S&P 500: time and holding periods S&P500 Sell (end of year) % -3.7% -15.7% -6.5% -2.1% -3.9% -3.2% -1.5% 1.0% -0.2% 1.0% 2.2% 2.1% 3.5% 4.2% 4.0% 4.5% 5.5% 4.8% 5.6% 5.6% 5.6% 5.3% 6.2% 6.7% 7.4% 8.0% 8.3% 7.6% 6.8% 5.5% 6.0% 6.1% 6.0% 6.2% 6.1% 4.1% 4.5% 4.7% 4.5% 4.7% 5.2% 5.3% 5.2% % -27.6% -12.6% -5.9% -7.2% -5.9% -3.5% -0.6% -1.7% -0.3% 1.1% 1.1% 2.7% 3.4% 3.3% 3.9% 4.9% 4.3% 5.2% 5.1% 5.2% 4.9% 5.9% 6.4% 7.1% 7.7% 8.1% 7.3% 6.5% 5.2% 5.7% 5.8% 5.7% 5.9% 5.9% 3.8% 4.2% 4.4% 4.3% 4.5% 5.0% 5.1% 5.0% % -9.2% -1.0% -4.0% -3.0% -0.7% 2.4% 0.7% 2.1% 3.4% 3.2% 4.8% 5.4% 5.2% 5.6% 6.7% 5.8% 6.7% 6.6% 6.6% 6.2% 7.2% 7.6% 8.4% 9.0% 9.3% 8.5% 7.6% 6.2% 6.7% 6.8% 6.6% 6.8% 6.7% 4.5% 4.9% 5.1% 5.0% 5.2% 5.7% 5.8% 5.6% % 22.4% 9.5% 7.4% 8.2% 10.5% 7.3% 8.1% 8.9% 8.1% 9.4% 9.8% 9.2% 9.3% 10.3% 9.1% 9.9% 9.6% 9.4% 8.9% 9.8% 10.1% 10.8% 11.3% 11.6% 10.6% 9.6% 8.1% 8.6% 8.6% 8.4% 8.5% 8.3% 6.0% 6.4% 6.6% 6.4% 6.5% 7.0% 7.1% 6.9% % 1.6% 1.4% 3.9% 7.4% 4.3% 5.6% 6.8% 6.2% 7.8% 8.3% 7.8% 8.1% 9.1% 8.0% 8.9% 8.6% 8.5% 8.0% 9.0% 9.4% 10.1% 10.7% 11.0% 10.0% 9.0% 7.4% 7.9% 8.0% 7.8% 7.9% 7.8% 5.4% 5.8% 6.0% 5.8% 6.0% 6.5% 6.6% 6.4% % -5.8% -0.3% 5.0% 1.8% 3.7% 5.4% 4.9% 6.8% 7.4% 6.9% 7.3% 8.5% 7.4% 8.4% 8.1% 8.0% 7.5% 8.5% 9.0% 9.8% 10.4% 10.7% 9.7% 8.7% 7.0% 7.6% 7.6% 7.5% 7.6% 7.5% 5.0% 5.5% 5.7% 5.5% 5.7% 6.2% 6.3% 6.1% % 6.2% 11.5% 5.6% 7.2% 8.6% 7.5% 9.4% 9.9% 9.1% 9.3% 10.5% 9.0% 10.0% 9.6% 9.4% 8.8% 9.8% 10.2% 11.0% 11.6% 11.9% 10.8% 9.6% 7.9% 8.4% 8.4% 8.2% 8.4% 8.2% 5.7% 6.1% 6.3% 6.1% 6.3% 6.8% 6.9% 6.7% % 17.1% 7.2% 8.8% 10.2% 8.7% 10.7% 11.0% 10.0% 10.2% 11.4% 9.7% 10.7% 10.2% 10.0% 9.3% 10.3% 10.8% 11.6% 12.2% 12.4% 11.2% 10.0% 8.2% 8.7% 8.7% 8.5% 8.7% 8.5% 5.8% 6.3% 6.5% 6.3% 6.4% 6.9% 7.0% 6.8% % 5.0% 7.9% 9.8% 8.1% 10.5% 10.9% 9.8% 10.0% 11.3% 9.5% 10.6% 10.1% 9.9% 9.1% 10.3% 10.7% 11.6% 12.2% 12.5% 11.2% 9.9% 8.0% 8.6% 8.6% 8.4% 8.6% 8.4% 5.6% 6.1% 6.3% 6.1% 6.3% 6.8% 6.9% 6.7% % 1.1% 5.8% 4.7% 8.2% 9.1% 8.0% 8.5% 10.1% 8.3% 9.6% 9.1% 9.0% 8.2% 9.5% 10.0% 10.9% 11.6% 11.9% 10.7% 9.4% 7.4% 8.0% 8.1% 7.9% 8.0% 7.9% 5.1% 5.6% 5.8% 5.6% 5.8% 6.4% 6.5% 6.3% % 14.8% 10.2% 13.3% 13.4% 11.4% 11.5% 13.0% 10.6% 11.8% 11.1% 10.7% 9.7% 11.0% 11.5% 12.4% 13.1% 13.3% 11.9% 10.4% 8.3% 9.0% 8.9% 8.7% 8.8% 8.6% 5.7% 6.2% 6.4% 6.2% 6.4% 6.9% 7.0% 6.8% % 8.4% 13.2% 13.3% 10.9% 11.1% 12.8% 10.2% 11.6% 10.8% 10.5% 9.4% 10.8% 11.4% 12.3% 13.0% 13.3% 11.8% 10.3% 8.0% 8.7% 8.7% 8.5% 8.6% 8.4% 5.4% 5.9% 6.1% 5.9% 6.1% 6.7% 6.8% 6.6% % 11.8% 12.4% 9.7% 10.1% 12.3% 9.4% 11.0% 10.3% 9.9% 8.8% 10.4% 11.0% 12.1% 12.8% 13.1% 11.6% 10.0% 7.6% 8.4% 8.4% 8.1% 8.3% 8.1% 5.0% 5.5% 5.8% 5.6% 5.8% 6.4% 6.6% 6.3% % 18.4% 12.7% 12.4% 14.7% 10.8% 12.5% 11.4% 10.9% 9.6% 11.3% 11.8% 12.9% 13.7% 14.0% 12.2% 10.5% 8.0% 8.8% 8.8% 8.5% 8.7% 8.4% 5.1% 5.7% 5.9% 5.7% 6.0% 6.6% 6.7% 6.5% % 7.7% 9.0% 12.6% 8.4% 10.8% 9.8% 9.5% 8.2% 10.1% 10.9% 12.1% 13.0% 13.3% 11.5% 9.7% 7.2% 8.0% 8.0% 7.8% 8.0% 7.8% 4.4% 5.0% 5.3% 5.1% 5.4% 6.0% 6.2% 6.0% % 6.7% 12.2% 7.1% 10.2% 9.2% 8.9% 7.5% 9.7% 10.6% 12.0% 12.9% 13.3% 11.4% 9.5% 6.8% 7.7% 7.7% 7.5% 7.7% 7.5% 4.0% 4.7% 5.0% 4.8% 5.1% 5.8% 5.9% 5.7% % 17.7% 8.9% 12.4% 10.7% 10.1% 8.3% 10.7% 11.6% 13.0% 14.0% 14.3% 12.1% 10.0% 7.1% 8.0% 8.1% 7.8% 8.0% 7.8% 4.1% 4.8% 5.1% 4.9% 5.2% 5.9% 6.1% 5.8% % 7.6% 12.6% 10.5% 9.7% 7.8% 10.6% 11.6% 13.2% 14.2% 14.5% 12.2% 9.9% 6.8% 7.8% 7.9% 7.6% 7.8% 7.6% 3.7% 4.5% 4.8% 4.6% 4.9% 5.7% 5.9% 5.6% % 7.2% 6.3% 6.4% 4.8% 8.5% 9.9% 11.9% 13.1% 13.6% 11.1% 8.8% 5.5% 6.7% 6.9% 6.6% 7.0% 6.8% 2.7% 3.6% 4.0% 3.8% 4.2% 5.0% 5.2% 5.0% % 13.5% 11.2% 7.9% 11.9% 12.9% 14.8% 15.9% 16.1% 13.1% 10.3% 6.6% 7.8% 7.9% 7.6% 7.9% 7.6% 3.3% 4.2% 4.5% 4.3% 4.7% 5.5% 5.7% 5.5% % 5.6% 3.2% 9.2% 11.0% 13.5% 14.9% 15.2% 12.0% 9.1% 5.2% 6.6% 6.8% 6.5% 6.9% 6.7% 2.2% 3.2% 3.6% 3.4% 3.9% 4.8% 5.0% 4.8% % 2.5% 10.8% 12.7% 15.4% 16.7% 16.9% 13.0% 9.6% 5.3% 6.9% 7.0% 6.7% 7.1% 6.9% 2.1% 3.1% 3.6% 3.4% 3.8% 4.8% 5.1% 4.8% % 12.8% 14.7% 17.6% 18.8% 18.7% 13.9% 10.0% 5.2% 6.9% 7.0% 6.7% 7.1% 6.9% 1.8% 2.9% 3.4% 3.2% 3.7% 4.7% 5.0% 4.7% % 23.8% 24.8% 24.5% 23.2% 16.7% 11.8% 6.0% 7.8% 7.9% 7.5% 7.9% 7.5% 2.0% 3.2% 3.7% 3.5% 4.0% 5.0% 5.3% 5.0% % 18.5% 22.7% 23.0% 21.7% 14.4% 9.1% 3.1% 5.4% 5.8% 5.5% 6.1% 5.9% 0.2% 1.5% 2.2% 2.1% 2.7% 3.8% 4.2% 3.9% % 25.3% 22.8% 13.4% 7.3% 0.7% 3.7% 4.3% 4.1% 5.0% 4.8% -1.2% 0.3% 1.1% 1.1% 1.7% 3.0% 3.4% 3.2% % 23.6% 20.7% 9.2% 2.9% -3.9% 0.2% 1.4% 1.6% 2.8% 2.8% -3.4% -1.6% -0.6% -0.6% 0.3% 1.7% 2.2% 2.0% % 2.6% -3.3% -9.7% -3.9% -1.9% -1.2% 0.4% 0.8% -5.8% -3.6% -2.4% -2.2% -1.2% 0.4% 1.0% 0.9% % -10.7% -12.3% -17.4% -8.7% -5.4% -4.1% -1.9% -1.2% -8.1% -5.5% -4.1% -3.7% -2.6% -0.8% 0.0% -0.1% % -20.5% -8.0% -4.1% -2.7% -0.3% 0.2% -7.8% -5.0% -3.4% -3.1% -1.9% 0.0% 0.8% 0.7% % -26.6% -4.8% -0.5% 0.3% 2.7% 2.8% -6.9% -3.8% -2.1% -1.9% -0.7% 1.3% 2.0% 1.8% % 15.8% 11.3% 11.7% 10.0% -3.1% 0.0% 1.5% 1.3% 2.4% 4.3% 4.8% 4.4% % 8.6% 5.7% 8.0% 6.9% -7.7% -3.4% -1.3% -1.2% 0.3% 2.6% 3.3% 3.0% % 7.8% 6.3% -11.4% -5.6% -2.9% -2.5% -0.7% 1.9% 2.8% 2.5% % Sold 12.8% 8.0% -15.7% -7.7% -4.0% -3.4% -1.2% 1.8% 2.8% 2.4% 2007 Bought 3.5% -27.1% -13.6% -7.8% -6.3% -3.4% 0.3% 1.6% 1.3% -30% % -21.1% -11.3% -8.6% -4.7% -0.2% 1.3% 1.1% % 16.5% 10.7% 11.2% 14.0% 13.4% 11.3% % 5.8% 8.0% 12.3% 12.0% 9.7% % 6.1% 12.3% 11.9% 9.3% % 19.1% 16.2% 11.7% %--20% -20%--10% -10%-0% 0%-10% 10%-20% 20%-30% 30%-30% 25.9% 18.1% 11.5% % 4.9% %

14 Ave. Annual Return Average Annual return S&P 500 risk stability measures Holding period length: % 7% 6% 25 yr 20 yr 15 yr 10 yr 5 yr 3 yr 2 yr 1 yr 5% 4% 3% 2% 1% 0% 0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 20% St.Dev. of Returns

15 Farmland: Low Equity correlation, positive CPI and Inflation effects C o n t e x t (US Farmland 26 State Returns 3-year rolling holding periods, )

16 Number of Farms 1960-present ERS-USDA

17 Acres per farm increasing ERS-USDA

18 Distribution by Sales Class - - Million Acres - - Ave Farm Sales from up to Farmland '15-'14 Size Ac. % Farmland 1,000 10, % 10, , % 100, , % 250, , , % 500,000 1,000, , % 1,000,000 >1,000, , % Total or ave million %

19 Farm Numbers and Acreage

20 Distribution by Sales Class

21 Size concentration and movement

22 Distribution by farm type and size % of farms % acres % Production # Farms Small Family 89.4% 45.3% 21.5% 1,856,318 MidSize Family 6.1% 23.4% 20.5% 125,760 Large Scale Family 3.4% 27.5% 47.6% 70,930 Non-Family 1.1% 3.8% 10.4% 23,266 Small Type # Farms % farms Retirement 281, Off-Farm 942, Farming low sales 522, Farming med. sales 109, Total Small 1,856, Family Farms comprise 99% of farms and 90% of production. Nearly 90% of farms produce less than $350k per year (Small) Non-family farms only 1% of farms but over 10% of production Source: USDA EIB, Hoppe McDonald (HM)

23 Age (it s complicated ) Slope =.48

24 More complex ops than ownership

25 Ownership and Operations Increasingly separable, but risk profile changes Tax advantaged asset to own into estate Crop Insurance and farm program incentives mixed and increasingly targeted Most corporate farms are family farms age of stockholders may not be meaningful number 2032a and 1031 not ag-specific Fairly concentrated relative to most other sectors Degrees of separation may matter

26 Today s Ag Tech Landscape from Granular s perspective PRECISION AG MACHINE TELEMETRY BENCHMARKING FARM MANAGEMENT SOFTWARE A B G U R S O I N AG ACCOUNTING LIVESTOCK MANAGEMENT SOFTWARE N O E M S Y S 26

27 On-line Comps (free.)

28 Parcel-level attributes (free )

29 Soil map units and acreage (free ) (I actually wondered how to compare to the others in the area that I knew )

30 Crop Histories (free )

31 Valuation app. (free )

32 Common to be asked about future path Is this time different? yes, I think

33 Aggregate US Debt Ratios, US Ag Sector

34 Farm mortgage interest rates and funding relationships 1980s loans could include: 80% LTV, 40-year amortization Ave Spread = 1.29% = 2.53% (-q2:2016)

35 What rates does Fed impact?

36 Interest rate market relatives

37 Percent Acres Insured, U.S.

38 Crop Insurance as Subsidy. Expected 2016 Corn Net Cost Insurance RP85 $/Acre -32 to to -6-6 to 0 0 to 9 9 to to 54 No data

39 Area or Group products Expected 2016 Corn Net Cost Insurance ARP90 $/Acre -84 to to to -4-4 to 7 7 to to 77 No data

40 Probability Impact on lower tail of revenue McLean Co. Illinois -- Corn Enterprise Unit 0.5 Probabilities of Revenue With Insurance $/acre $200 $300 $400 $500 $600 $700 $800 Revenue ($/acre) No Ins. YP85 RP-HPE85 RP85 AYP90 ARP90 ARPHPE90

41 Structural Issues in changing ownership Very low turnover about 1% per year at arm s length in row crop regions Restrictive Farmland Ownership Laws still exist Increasing compliance cost, increasing opportunity Rapidly advancing technical sophistication Future Policy - Farm Bill or Food Bill Institutional interest fits extremely well, but still de minimus scale

42 Changing consumer attribute demand Farm to fork movement - many channels Natural, local, fresh, low impact, etc. competing with certification programs (Organic, GMO-free, gluten free) Lack of standardization in measure of importance (healthfulness, toxicity, taste) and proxy production characteristics

43 Futurecasting Financialization likely to continue for the sector. Equity & indexing vehicles very positive developments Rationalization of recent incomes, lower cap rates Attribute Demand (e.g., non-gmo) becomes more direct public signal, but marginally impacts production key Some positive outcomes for capital providers likely, balance sheet effects unlikely to trigger bubble, low cap rates remain for some time (economy wide, not ag-specific) What asset would you rather own remains important

44 Questions/Discussion Bruce J. Sherrick Find us on the web at:

Fourth Quarter 2017 NCREIF Indices Review February 9, 2018

Fourth Quarter 2017 NCREIF Indices Review February 9, 2018 Fourth Quarter 2017 NCREIF Indices Review February 9, 2018 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Doug Herzbrun Global Head of Research CBRE Global Investors Disclaimer Today we

More information

Third Quarter 2017 NCREIF Indices Review. Fall Conference November 7, 2017

Third Quarter 2017 NCREIF Indices Review. Fall Conference November 7, 2017 Third Quarter 2017 NCREIF Indices Review Fall Conference November 7, 2017 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research John Ehli Portfolio Manager

More information

Second Quarter 2016 NCREIF Indices Review. August 4, 2016 NCREIF-SMU Summer Academy

Second Quarter 2016 NCREIF Indices Review. August 4, 2016 NCREIF-SMU Summer Academy Second Quarter 2016 NCREIF Indices Review August 4, 2016 NCREIF-SMU Summer Academy Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research Mike Sobolik

More information

Portfolio Strategy Group

Portfolio Strategy Group PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, November 15, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Nov-5 Feb-6 May-6 Aug-6 Nov-6

More information

Portfolio Strategy Group

Portfolio Strategy Group PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, September 27, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Sep-5 Dec-5 Mar-6 Jun-6 Sep-6

More information

Summary of Results for the First Half of FY2015/3

Summary of Results for the First Half of FY2015/3 Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial

More information

Second Quarter 2017 NCREIF Indices Review August 8, 2017

Second Quarter 2017 NCREIF Indices Review August 8, 2017 Second Quarter 2017 NCREIF Indices Review August 8, 2017 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research Arthur Jones Director, Commercial Real

More information

CENTRALE. Monetary. compared. domestic. million.

CENTRALE. Monetary. compared. domestic. million. CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased

More information

Walgreens Pharmacy 2551 W. Main Street Alhambra, CA $10,300,000

Walgreens Pharmacy 2551 W. Main Street Alhambra, CA $10,300,000 Walgreens Pharmacy 2551 W. Main Street Alhambra, CA 91801 $10,300,000 INVESTMENT HIGHLIGHTS Rare LA County, Walgreens Net Leased Offering Population in Excess of 265,328 Within 3 Miles Located Blocks Away

More information

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1- BANK HANDLOWY W WARSZAWIE S.A. 1Q 29 consolidated financial results -1- Macroeconomic situation in 1Q 29 Deep drop in industrial output in January and February, albeit business confidence indicators suggest

More information

Investor Presentation June 2012 NASDAQ: CEMI

Investor Presentation June 2012 NASDAQ: CEMI Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act

More information

Fully Employed MBA (MGMT FE)

Fully Employed MBA (MGMT FE) Fully Employed MBA (MGMT FE) 1 Fully Employed MBA (MGMT FE) Courses MGMT FE 200. Responding to Dynamic Times: Thinking Strategically in Organizations. 6 Units. Focuses on the strategic and organizational

More information

How Residential Development Gets Financed

How Residential Development Gets Financed How Residential Development Gets Financed Raquel Favela, Chief of Economic Development & Neighborhood Services Jackie Rodarte, Assistant Director, Housing & Neighborhood Revitalization 1 Understanding

More information

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Telekom Austria Group Results for the 1st Quarter May 27, 2003 Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those

More information

Welcome to LG Electronics

Welcome to LG Electronics Welcome to LG Electronics April 21, 2004 As a note, this presentation has been prepared based on internal audited figures and final figures may change due to the results of independent auditors review.

More information

MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.

MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr. MANAGEMENT MGMT 0021 THE MANAGEMENT PROCESS 3 cr. An introduction designed to emphasize the basic principles, practices, and terminology essential to the understanding of contemporary business and its

More information

Forward-Looking Statements

Forward-Looking Statements Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.

More information

The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation.

The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation. The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation. The Verde Mountain Fund offers a unique investment opportunity for both

More information

Monday, September 11 Start Time End Time Session Type Product Focus Session name 8:00 am 12:00 pm Training Axys, APX APX/Axys Advanced Report Writer

Monday, September 11 Start Time End Time Session Type Product Focus Session name 8:00 am 12:00 pm Training Axys, APX APX/Axys Advanced Report Writer Monday, September 11 8:00 am 12:00 pm Training Axys, APX APX/Axys Advanced Report Writer Pro Master Class ($395.00) 8:00 am 12:00 pm Training Precision LM Precision LM Database Structure ($395.00) 8:00

More information

High Value Soybean Composition

High Value Soybean Composition Fact Sheet #39 November 23, 1998 Purdue University High Value Soybean Composition Dirk E. Maier, Jason Reising, & Jenni L. Briggs, Agricultural & Biological Engineering Kelly M. Day & Ellsworth P. Christmas,

More information

Economic Impact of Highly Pathogenic Avian Influenza (HPAI) on Poultry in Iowa

Economic Impact of Highly Pathogenic Avian Influenza (HPAI) on Poultry in Iowa Economic Impact of Highly Pathogenic Avian Influenza (HPAI) on Poultry in Iowa Prepared For: Prepared By: August 2015 Table of Contents Executive Summary... 3 Background... 4 Methodology... 10 IMPLAN Model

More information

Table Egg Industry Outlook

Table Egg Industry Outlook Agricultural Finance Table Egg Industry Outlook Executive summary Table egg prices have experienced increased volatility over the past two years. Avian flu decimated layer flocks in 05, and in response,

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,

More information

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce

More information

Altria Group Inc. Ticker: MO

Altria Group Inc. Ticker: MO Altria Group Inc. Ticker: MO Business Description Altria Group Inc. through its subsidiaries manufactures and sells cigarettes, other tobacco products, machine-made large cigars and pipe tobacco. It also

More information

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-JUNE 2013 Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Forward Looking Statement This presentation includes forward-looking statements, including financial projections, relating

More information

PRIME investment opportunity in Beverly Hills S. Roxbury Dr. Beverly Hills, CA 90212

PRIME investment opportunity in Beverly Hills S. Roxbury Dr. Beverly Hills, CA 90212 PRIME investment opportunity in Beverly Hills One of the highest-profile and most sought-after locations in the world! The Roxbury address has enormous cache and is within walking distance to everything

More information

Seller-financing opportunity in Redondo 2408 Grant Ave Redondo Beach, CA 90278

Seller-financing opportunity in Redondo 2408 Grant Ave Redondo Beach, CA 90278 Seller-financing opportunity in Redondo Large, all electric units in a highly visible location Grant is a main artery that runs the length of North Redondo Well-maintained by original owner! NEVER been

More information

The Effects of Soybean Protein Changes on Major Agricultural Markets

The Effects of Soybean Protein Changes on Major Agricultural Markets The Effects of Soybean Protein Changes on Major Agricultural Markets Prem V. Premakumar Working Paper 96-WP 16 June 1996 Center for Agricultural and Rural Development Iowa State University Ames, Iowa 511-17

More information

Coloplast A/S. Investor presentation 1H 2005/06

Coloplast A/S. Investor presentation 1H 2005/06 Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound

More information

REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS

REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS IRVING, Texas August 8, 2018 Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage

More information

Director of Donor Partnerships

Director of Donor Partnerships TULSA Community Foundation Tulsa Community Foundation (TCF) was founded in late 1998 and exists to make charitable giving more meaningful and efficient. Hundreds of individuals and corporations make all

More information

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE Occasion: Initial coverage +37% +71% 100% one-week return? s share price has dropped by more than 50% since the announcement of the current and ongoing public offering. In theory the share price should

More information

DELICA D:5 ACTIVE GEAR 0

DELICA D:5 ACTIVE GEAR 0 DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion

More information

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator

More information

CRS Report for Congress Received through the CRS Web

CRS Report for Congress Received through the CRS Web Order Code 95-129 ENR Updated November 3, 2003 CRS Report for Congress Received through the CRS Web Tobacco Price Support: An Overview of the Program Jasper Womach Agricultural Policy Specialist Resources,

More information

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE Occasion: Company announcements +32% +58% Pearls on a string has had troublesome times, but now everything seems to fall into place. With a new CEO in charge the phase II trials close to commencing in

More information

Sponsors. Editors W. Christopher Scruton Stephen Claas. Layout David Brown

Sponsors. Editors W. Christopher Scruton Stephen Claas. Layout David Brown Sponsors University of Minnesota College of Veterinary Medicine College of Agricultural, Food and Environmental Sciences Extension Service Swine Center Editors W. Christopher Scruton Stephen Claas Layout

More information

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK Small-Cap Research February 2, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive

More information

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor

More information

Impact of excise tax on price, consumption and revenue

Impact of excise tax on price, consumption and revenue Impact of excise tax on price, consumption and revenue Introduction Increase in tobacco tax that leads to price increase is expected to reduce tobacco consumption and improve public health. This section

More information

STATE OF NORTH DAKOTA PUBLIC SERVICE COMMISSION FINDINGS OF FACT, CONCLUSIONS OF LAW AND ORDER. June 27, Appearances

STATE OF NORTH DAKOTA PUBLIC SERVICE COMMISSION FINDINGS OF FACT, CONCLUSIONS OF LAW AND ORDER. June 27, Appearances STATE OF NORTH DAKOTA PUBLIC SERVICE COMMISSION Northern States Power Company Natural Gas Rate Increase Application FINDINGS OF FACT, CONCLUSIONS OF LAW AND ORDER June 27, 2001 Appearances Commissioners:

More information

Q Investor Kit JANUARY-MARCH 2013

Q Investor Kit JANUARY-MARCH 2013 Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf

More information

M e d i a s e t G r o u p

M e d i a s e t G r o u p M e d i a s e t G r o u p 11 th May 2004 2004 First Quarter Results M e d i a s e t G r o u p BROADCASTING MEDIASET 2004 1Q 24 Hours Audience Trend Individuals Share Points Vs 1Q 2003 OTHER SATELLITE 44.0%

More information

6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store

6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store Actual Store Low Price & Great Value $5,6, 6.% CAP Rate Open & paying rent--available for immediate sale Lower price point and great value Offered free & clear; loans available today with as little as

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

METVIX PDT ON THE MARKET IN GERMANY AND UK

METVIX PDT ON THE MARKET IN GERMANY AND UK METVIX PDT ON THE MARKET IN GERMANY AND UK PhotoCure ASA First Quarter Report 2003 Highlights: The launches of Metvix PDT by Galderma in February in Germany and in May in the UK, have triggered milestone

More information

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06

VICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 VICAL INC FORM 8-K (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 Address 10390 PACIFIC CENTER COURT. SAN DIEGO, CA 92121-4340 Telephone 858-646-1100 CIK 0000819050 Symbol VICL SIC

More information

ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011

ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 STRUCTURE 1. National economy 2. International economy 3. Outlook 2 CENTRALE

More information

Extremely Rare 24 hour Store Huntington Beach, CA

Extremely Rare 24 hour Store Huntington Beach, CA Extremely Rare 24 hour Store Huntington Beach, CA Actual Store Exclusively Listed Investment Offering Absolute NNN Walgreens in Huntington Beach, CA. High traffic location with average household income

More information

commercial real estate

commercial real estate August 15 Asset Management Documeent title on one or two Defensive lines in Gustan investing Book in pt U.S. commercial real estate TIAA-CREF Global Real Estate Strategy & Research Martha Peyn, Ph.D. Managing

More information

Mortgage Rate Sheet Intermediary Rate Sheet Rates Effective From 15th December 2017

Mortgage Rate Sheet Intermediary Rate Sheet Rates Effective From 15th December 2017 Mortgage Sheet Intermediary Sheet s Effective From 15th December 2017 Contents s... Purchase, 4 & 5...2,3 Family Spingboard & Help to Buy Purchase s...5...2,3, 4 & 5 s...6,7 Family Spingboard, Scotland

More information

Tobacco Consumption in the United States, 1880 to By Benno K. Milmore and Arthur G. Conover

Tobacco Consumption in the United States, 1880 to By Benno K. Milmore and Arthur G. Conover Consumption in the United States, 88 to 954 By Benno K. Milmore and Arthur G. Conover The trend of cigarette consumption in the United States in recent years has been the subject of much comment and speculation.

More information

Iowa s Changing Swine Industry

Iowa s Changing Swine Industry Animal Industry Report AS 652 ASL R2158 2006 Iowa s Changing Swine Industry Mark S. Honeyman Iowa State University, honeyman@iastate.edu Michael D. Duffy Iowa State University Recommended Citation Honeyman,

More information

MannKind Corporation. BAEZ & IPE Inc. Inhaled Insulin: Next Generation Diabetes Therapy

MannKind Corporation. BAEZ & IPE Inc. Inhaled Insulin: Next Generation Diabetes Therapy Millions of Shares BAEZ & IPE Inc. MannKind Corporation Inhaled Insulin: Next Generation Diabetes Therapy Afresa is well positioned to capture the inhaled insulin segment and to cut into the short-acting

More information

Group financial results for the first quarter 2008

Group financial results for the first quarter 2008 Helmut Perlet, Member of the Board of Management Group financial results for the first quarter 2008 Journalists Conference Call May 9th, 2008 Group: robust earnings in stormy weather (EUR mn) Quarterly

More information

Interim report Second quarter 2017 and subsequent events (Unaudited)

Interim report Second quarter 2017 and subsequent events (Unaudited) SERODUS ASA Interim report Second quarter 2017 and subsequent events (Unaudited) August 2017 2017-08-15 Q2-2017 report ABOUT SERODUS Serodus is a private biotech company with a focus on diabetic comorbidities

More information

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018 CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm

More information

Critical Access Hospital Medicare Reimbursement Update and Financial Improvement Tools

Critical Access Hospital Medicare Reimbursement Update and Financial Improvement Tools acumen Critical Access Hospital Medicare Reimbursement Update and Financial Improvement Tools Presented by Ann King White, CPA & Tammy Rivera, CPA BKD, LLP January 16, 2018 insight ideas attention reach

More information

Mercy Health Corporation (WI)

Mercy Health Corporation (WI) Mercy Health Corporation (WI) 1 Illinois Finance Authority, Revenue Bonds (Mercy Health Corporation), Series, $475,020,000, Dated: May 18, 2 Wisconsin Health and Educational Facilities Authority, Revenue

More information

OraSure Technologies. JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014

OraSure Technologies. JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014 OraSure Technologies JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014 Forward-Looking Statements These slides and the associated presentation contain certain forward-looking statements, including

More information

NOVO NORDISK. Analyst: Recommendation: HOLD DATE: Industry: Drug manufacturers

NOVO NORDISK. Analyst: Recommendation: HOLD DATE: Industry: Drug manufacturers NOVO NORDISK Analyst: Recommendation: HOLD DATE: 11.11.2015 Industry: Drug manufacturers Share price 375,00 DKK Homepage www.novonordisk.com Ticker NVO Number of shares (000) 2.563.800 Target price 406,14

More information

Silicon Valley Housing and Economic Outlook

Silicon Valley Housing and Economic Outlook White Paper Silicon Valley Housing and Economic Outlook Santa Clara County, San Mateo County Prepared by John Burns Real Estate Consulting for Pacific Union 11.5.2014 Santa Clara County The booming tech

More information

NASDAQ: FHCO 2016 Annual Meeting

NASDAQ: FHCO 2016 Annual Meeting NASDAQ: FHCO 2016 Annual Meeting Q1 2016 At a Glance NASDAQ Core product FHCO FC2 Female Condom Gross margin ~66% Operating margin ~29% Total current assets $24 million no L/T debt Profitable Starting

More information

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion

More information

Investing in Dental Practice Management: Key Issues and Notable Transactions

Investing in Dental Practice Management: Key Issues and Notable Transactions Investing in Dental Practice Management: Key Issues and Notable Transactions SCOTT BECKER, PARTNER 312.750.6016 sbecker@mcguirewoods.com 77 West Wacker Drive, Suite 4100 Chicago, Illinois 60601 LAURALEE

More information

MDxHealth. Strong outlook for Research Note.

MDxHealth. Strong outlook for Research Note. Research Note MDxHealth Strong outlook for 2017 Chief Research Analyst Marcel Wijma MSc +1 (917) 460 6185 (US) +31 (6) 8489 2954 (NL) m.wijma@leeuwenhoeck.com http://www.leeuwenhoeck.com Date: 23 February

More information

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011 Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai

More information

Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago

Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago American Heart Association/American Stroke Association Advocacy Coordinating Committee Dallas

More information

For personal use only

For personal use only Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for

More information

Investment in MGC Pharmaceuticals

Investment in MGC Pharmaceuticals Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information

More information

The Strategic Marketing Institute Working Paper

The Strategic Marketing Institute Working Paper The Strategic Marketing Institute Working Paper The Market for Organic and Fortified Eggs William A. Knudson 2-0104 January 2004 Introduction Eggs are an important part of the American diet. According

More information

FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO

FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO DISCLAIMER This document contains certain forward-looking information that is subject toa number of factors that may influence the accuracy of

More information

Results Briefing. 15 ~ 17 May 2007

Results Briefing. 15 ~ 17 May 2007 Results Briefing 1Q Q & 3 Months ended 31 Mar. 2007 15 ~ 17 May 2007 Content Key highlights Financial Corporate Financial results Industry overview Q&A Appendix 2 2 Key Highlights for the Period Key Highlights

More information

Farm Level Effects an Increase in Federal Cigarette Taxes under Two Scenarios: Keep vs Eliminate the Tobacco Program

Farm Level Effects an Increase in Federal Cigarette Taxes under Two Scenarios: Keep vs Eliminate the Tobacco Program U.S. Department of Agriculture Agricultural Outlook Forum 1998 February 23 & 24, 1998 Farm Level Effects an Increase in Federal Cigarette Taxes under Two Scenarios: Keep vs Eliminate the Tobacco Program

More information

1Q2017 法人說明會 Jun. 9, 2017

1Q2017 法人說明會 Jun. 9, 2017 1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic

More information

NORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director

NORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director Robert Ullman Managing Director rullman@dinancapital.com 45.63.44 NORTH AMERICAN DERMATOLOGY M&A Activity and Valuation Trends Q4 205 William Downing Director wdowning@dinancapital.com 602.734.0682 Michael

More information

Small-Cap Research. VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set Supports Earlier Findings of High Accuracy in Colon Cancer Detection OUTLOOK

Small-Cap Research. VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set Supports Earlier Findings of High Accuracy in Colon Cancer Detection OUTLOOK Small-Cap Research September 12, 2014 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set

More information

Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results

Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results August 11, 2008 Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results Conference Call/Webcast to be Held Monday, August 11 at 10:00 AM EDT CEDAR KNOLLS, N.J., Aug 11, 2008 /PRNewswire-FirstCall

More information

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar 2018-08-16 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION A Swedish

More information

Presentation First quarter 2006

Presentation First quarter 2006 Immunity for Life TM Presentation First quarter 2006 CEO Gunnar Rørstad CFO Finn Samuelsen 10 May 2006 Highlights - operations Inclusion of patients almost completed in the the phase II clinical trial

More information

Investor Presentation

Investor Presentation Investor Presentation January 2012 Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933,

More information

Successful Senior Marketing Sales Support Materials

Successful Senior Marketing Sales Support Materials Successful Senior Marketing Sales Support Materials 1. Contents of This DVD DVD Table of Contents PDF 2. Slide Presentation System Slide Set #1 The Challenges of Growing Older PPT Slide Set #2 Aging Seniors

More information

Merrill Lynch's Global Pharmaceutical, Biotechnology, and Medical Device Conference. February 7, 2007

Merrill Lynch's Global Pharmaceutical, Biotechnology, and Medical Device Conference. February 7, 2007 Merrill Lynch's Global Pharmaceutical, Biotechnology, and Medical Device Conference February 7, 2007 Information related to forward-looking statements This presentation includes forward-looking statements

More information

HALOZYME REPORTS SECOND QUARTER 2018 RESULTS

HALOZYME REPORTS SECOND QUARTER 2018 RESULTS Contacts: Robert H. Uhl Managing Director Westwicke Partners, LLC 858-356-5932 robert.uhl@westwicke.com Laurie Stelzer 858-704-8222 ir@halozyme.com FOR IMMEDIATE RELEASE HALOZYME REPORTS SECOND QUARTER

More information

Walgreens. Absolute NNN Single Tenant - Bastrop, LA. Offering Memorandum. Beezie Landry

Walgreens. Absolute NNN Single Tenant - Bastrop, LA. Offering Memorandum. Beezie Landry Beezie Landry 109 Northpark Blvd., Ste. 300 Covington, LA 70433 985-898-2022 blandry@stirlingprop.com Walgreens Absolute NNN Single Tenant - Offering Memorandum 1 information to the extent such purchaser/lessee

More information

A GLOBAL LEADER IN PERSONALIZED NUTRITION

A GLOBAL LEADER IN PERSONALIZED NUTRITION A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking

More information

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK Small-Cap Research November 16, 2017 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final

More information

Roof Type: Roof Material: Foundation: Ext. Material: Exterior: Patio: 0 Garage: Heat Source: Fireplace #: 0 BldgCondition: Neighborhood:

Roof Type: Roof Material: Foundation: Ext. Material: Exterior: Patio: 0 Garage: Heat Source: Fireplace #: 0 BldgCondition: Neighborhood: Parcel #: 26488 Ref Parcel #: 7329DB 22 Owner: CoOwner: Owner Phone: Site: Mail: Legal: School Dist: Brill Investments LLC POLK COUNTY PROPERTY PROFILE INFORMATION 2625 Salem Dallas Hwy NW SalemOR9734

More information

Project for Alternative Livelihoods in Eastern Afghanistan (PAL)

Project for Alternative Livelihoods in Eastern Afghanistan (PAL) Project for Alternative Livelihoods in Eastern Afghanistan (PAL) 1 Understanding Rural Livelihoods and Addressing the Causes of Opium Poppy Cultivation in Eastern Afghanistan Abridged Version 1. Introduction

More information

QUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010

QUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010 QUALITAS MEDICAL GROUP LIMITED CORPORATE PRESENTATION January 2010 Contents Our Business Corporate Developments Growth Strategies Financial Highlights Summary Business Overview Who We Are Established in

More information

Industry experience in consortium i.e. from BEE party or non-bee partners

Industry experience in consortium i.e. from BEE party or non-bee partners A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:

More information